Lacerta Therapeutics

Florida’s Life Science Leaders United To Celebrate 25 Years of Innovation and Growth in the State

BioFlorida's 25th Annual Conference united statewide leaders of Florida's life sciences industry representing biopharmaceutical, medical technology, and digital health companies, globally recognized research universities and research institutions, and the state's health systems to spotlight the continued momentum and success in science, business, and public policy and spur collaboration and future growth.

Concept Companies and Lacerta Therapeutics Form a Strategic Partnership Around Facilities Expansion and Financing

Concept Companies, a national commercial real estate developer with a specialty across multiple asset classes including science and technology, and Lacerta Therapeutics, Inc., a leader in the AAV gene therapy space, today announced a strategic collaboration providing Lacerta with access to financing to support expansion of operations and new facilities. The financing is being provided via Agility Venture Capital, the funding arm of Concept Companies. 

Concept Companies Leads Development Efforts on Second Phase for Lacerta Therapeutics in Alachua’s Progress District

Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company. The site will be located adjacent to Lacerta Therapeutics' current location in Alachua, Florida, in Copeland Park, which Lacerta has occupied since 2020.

Lacerta Therapeutics Expands Executive Leadership Team

UF startup Lacerta Therapeutics, a preclinical-stage gene therapy company, announces an expansion in the executive leadership team: illustrating Lacerta’s commitment to developing a constellation of gene-based therapies.